EP2588090
PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.7.2011EP published:
19.4.2017EP application number:
11732405.3
EPO information:
European Patent Register
Max expiry date:
30.6.2031
Title:
PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Timeline
Today
1.7.2011EP application
19.4.2017EP Publication
Owner
Name:
KRKA, tovarna zdravil, d.d., Novo mestoAddress:
Smarjeska cesta 6, 8501, Novo mesto, SI
Inventor
Name:
KROSELJ, VesnaAddress:
Ljubljana, SI
Name:
JURSA KSELA, SonjaAddress:
Novo mesto, SI
Priority
Number:
201000209Date:
12.7.2010Country:
SI
Number:
201000196Date:
1.7.2010Country:
SI
Classification
Categories:
A61K 9/50